首页> 外文期刊>亚太热带生物医学杂志:英文版 >Production and purification of a bioactive substance against multi-drug resistant human pathogens from the marine-sponge-derived Salinispora sp.
【24h】

Production and purification of a bioactive substance against multi-drug resistant human pathogens from the marine-sponge-derived Salinispora sp.

机译:从海洋海绵衍生的Salinispora sp。生产和纯化抗多种药物人类病原体的生物活性物质。

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To isolate,purify,characterize,elucidate structure and evaluate bioactive compounds from the sponge-derived Salinispora sp.FS-0034.Methods:The symbiotic actinomycete strain FS-0034 with an interesting bioactivity profile was isolated from the Fijian marine sponge Theonella sp.Based on colony morphology and obligatory requirement of seawater for growth,and mycelia morphological characteristics the isolate FS-0034 was identified as a Salinispora sp.The bioactive compound was identified by using various spectral analysis of ultraviolet,high resolution electrospray ionization mass spectroscopy,H nuclear magnetic resonance,correlated spectroscopy and heteronuclear multiple bond coherence spectral data.A minimum inhibitory concentration assay were performed to evaluate the biological properties of the pure compound against multi-drug resistant pathogens.Results:Bioassay guided fractionation of the ethyl acetate extract of the culture of Salinispora sp.FS-0034 by different chromatographic methods yielded the isolation of an antibacterial compound,which was identified as rifamycin W(compound 1).Rifamycin W was reported for its potent antibacterial activity against methicillin-resistant Staphylococcus aureus,wild type Staphylococcus aureus and vancomycin-resistant Enterococcus faecium and displayed minimum inhibitory concentrations of 15.62,7.80 and 250.00 μg/mL,respectively.Conclusions:The present study reported the rifamycin W from sponge-associated Salinispora sp.and it exhibited appreciable antibacterial activity against multi-drug resistant human pathogens which indicated that sponge-associated Actinobacteria are significant sources of bioactive metabolites.
机译:目的:分离,纯化,鉴定,阐明结构并评估海绵衍生盐藻FS-0034的生物活性化合物。方法:从斐济海洋海绵Theonella sp中分离具有有趣生物活性的共生放线菌菌株FS-0034。根据菌落形态和海水生长的强制性要求,并根据菌丝体的形态特征,将分离株FS-0034鉴定为Salinispora sp。通过紫外,高分辨电喷雾电离质谱,紫外分光光度法对生物活性化合物进行鉴定。核磁共振,相关光谱和异核多键相干光谱数据。进行了最小抑菌浓度测定,以评估纯化合物对耐多药病原体的生物学特性。结果:生物测定指导分离培养物中乙酸乙酯提取物不同色谱法鉴定Salinispora sp.FS-0034瑞福霉素W的分离方法被证明是利福霉素W(化合物1)。据报道,利福霉素W对耐甲氧西林金黄色葡萄球菌,野生型金黄色葡萄球菌和耐万古霉素肠球菌的抑菌作用强,显示最低限度。结论:本研究报道了海绵相关的Salinispora sp。中的利福霉素W,其对多种药物耐药的人类病原体表现出明显的抗菌活性,表明海绵相关的放线菌。是生物活性代谢物的重要来源。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号